CN Patent

CN114901286B — 涉及二芳基巨环化合物的组合疗法

Assigned to Tepu Pharmaceutical · Expires 2024-05-10 · 2y expired

What this patent protects

本发明涉及用二芳基巨环与KRAS抑制剂、如KRAS G12C抑制剂的组合来治疗癌症的方法和组合物。

USPTO Abstract

本发明涉及用二芳基巨环与KRAS抑制剂、如KRAS G12C抑制剂的组合来治疗癌症的方法和组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN114901286B
Jurisdiction
CN
Classification
—
Expires
2024-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Tepu Pharmaceutical
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.